Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 39

1.

Adherence to asthma controller medication regimens.

Stempel DA, Stoloff SW, Carranza Rosenzweig JR, Stanford RH, Ryskina KL, Legorreta AP.

Respir Med. 2005 Oct;99(10):1263-7.

2.
3.

Advair: combination treatment with fluticasone propionate/salmeterol in the treatment of asthma.

Nelson HS.

J Allergy Clin Immunol. 2001 Feb;107(2):398-416. Review.

PMID:
11174215
4.

Inhaled salmeterol/fluticasone propionate: a review of its use in asthma.

Reynolds NA, Lyseng-Williamson KA, Wiseman LR.

Drugs. 2005;65(12):1715-34. Review.

PMID:
16060707
5.

Salmeterol/fluticasone propionate combination.

Spencer CM, Jarvis B.

Drugs. 1999 Jun;57(6):933-40; discussion 941-3. Review.

PMID:
10400406
6.

Montelukast as add-on therapy to inhaled corticosteroids in the treatment of mild to moderate asthma: a systematic review.

Joos S, Miksch A, Szecsenyi J, Wieseler B, Grouven U, Kaiser T, Schneider A.

Thorax. 2008 May;63(5):453-62. doi: 10.1136/thx.2007.081596. Review.

PMID:
18443162
7.
8.

[A rational combination for the treatment of asthma. Salmeterol and fluticasone in one preparation].

Wettengel R, Steinkamp G.

Pneumologie. 1999 Sep;53(9):426-32. Review. German. No abstract available.

PMID:
10544652
9.

[Budesonide/formoterol maintenance and reliever therapy. A new treatment approach for adult patients with asthma].

Korn S, Vogelmeier C, Buhl R.

Med Klin (Munich). 2008 May 15;103(5):299-310. doi: 10.1007/s00063-008-1050-y. Review. German.

PMID:
18484216
10.
11.

Comparative effect of body mass index on response to asthma controller therapy.

Sutherland ER, Camargo CA Jr, Busse WW, Meltzer EO, Ortega HG, Yancey SW, Emmett AH, Stempel DA.

Allergy Asthma Proc. 2010 Jan-Feb;31(1):20-5. doi: 10.2500/aap.2010.31.3307. Review.

PMID:
20167142
12.

Salmeterol/fluticasone combination in the treatment of COPD.

Chung KF.

Int J Chron Obstruct Pulmon Dis. 2006;1(3):235-42. Review.

13.

Salmeterol/fluticasone propionate combination product in asthma. An evaluation of its cost effectiveness vs fluticasone propionate.

[No authors listed]

Pharmacoeconomics. 1999;16 Suppl 2:i-viii, 1-34. Review. No abstract available.

PMID:
10724799
14.

Fluticasone propionate: a potent inhaled corticosteroid for the treatment of asthma.

Staresinic AG, Sorkness CA.

Expert Opin Pharmacother. 2000 Sep;1(6):1227-44. Review.

PMID:
11249490
15.

Newer therapeutic agents for asthma.

Deykin A, Israel E.

Adv Intern Med. 1999;44:209-37. Review.

PMID:
9929710
16.

Asthma therapy in pediatric patients: a systematic review of treatment with montelukast versus inhaled corticosteroids.

Massingham K, Fox S, Smaldone A.

J Pediatr Health Care. 2014 Jan-Feb;28(1):51-62. doi: 10.1016/j.pedhc.2012.11.005. Review.

PMID:
23312367
17.

Single-inhaler combination therapy for asthma: a review of cost effectiveness.

Akazawa M, Stempel DA.

Pharmacoeconomics. 2006;24(10):971-88. Review.

PMID:
17002480
18.

Revising old principles of inhaled treatment in new fixed combinations for asthma.

Scichilone N, Rossi A, Melani A.

Pulm Pharmacol Ther. 2015 Aug;33:32-8. doi: 10.1016/j.pupt.2015.06.001. Review.

PMID:
26079566
19.

A valid option for asthma control: Clinical evidence on efficacy and safety of fluticasone propionate/formoterol combination in a single inhaler.

Latorre M, Paggiaro P, Canonica W, Foschino MP, Papi A.

Pulm Pharmacol Ther. 2015 Oct;34:31-6. doi: 10.1016/j.pupt.2015.08.004. Review.

PMID:
26278189
20.

Bronchodilator therapy in asthma.

Boyd G.

Acta Microbiol Immunol Hung. 1998;45(1):143-5. Review. No abstract available.

PMID:
9595165

Supplemental Content

Support Center